U.S. Metals and Mining Stock News

NasdaqGS:AEVA
NasdaqGS:AEVAElectronic

Reassessing Aeva Technologies (AEVA) Valuation After A Very Large One Year Share Price Jump

If you are wondering whether Aeva Technologies' current share price lines up with its real value, you are not alone. This article is here to unpack that question step by step. The stock last closed at US$15.16, with returns of 7.0% over 7 days, 19.0% over 30 days, 18.9% year to date, a very large 1 year return that sits well above 400%, a 3 year return of 84.9%, and a 5 year return of a 79.2% decline. These moves have put Aeva back on many watchlists, as investors reassess how the market is...
NYSE:KOF
NYSE:KOFBeverage

Is It Time To Revisit Coca-Cola FEMSA (NYSE:KOF) After The Recent Share Price Pullback?

If you are wondering whether Coca-Cola FEMSA. de is still offering fair value at around US$97.16 per share, this article will walk through what the current price might be implying about the business. The stock has seen mixed recent returns, with a 6.8% decline over the past week and a 13.7% decline over the last month, set against longer term returns of 2.4% year to date, 13.6% over 1 year, 45.3% over 3 years and 154.2% over 5 years. Recent attention around Coca-Cola FEMSA. de has centered...
NYSE:H
NYSE:HHospitality

Is It Time To Reassess Hyatt Hotels (H) After The Recent Share Price Pullback?

If you are wondering whether Hyatt Hotels' share price still reflects good value, or if you are late to the story, this article will walk through what the numbers say about the stock today. Hyatt last closed at US$139.30, with a 6.9% decline over 7 days and a 17.4% decline over 30 days, while the stock shows a 14.4% return over 1 year, 33.0% over 3 years and 62.2% over 5 years. Recent headlines around Hyatt have focused on its ongoing position as a global hotel operator and the broader...
NasdaqGS:DYN
NasdaqGS:DYNBiotechs

Dyne Therapeutics DMD And DM1 Progress Sharpens Rare Disease Investment Case

Dyne Therapeutics plans to submit an accelerated application for its Duchenne muscular dystrophy drug, targeting a potential commercial launch in early 2027. The company has completed enrollment in its Phase 1/2 trial in myotonic dystrophy type 1 and started a Phase 3 trial for DYNE-101 in DM1. New long term DELIVER trial data report meaningful improvements in lung and cardiac function in patients with Duchenne muscular dystrophy. For investors watching NasdaqGS:DYN, these clinical and...
NYSE:SBH
NYSE:SBHSpecialty Retail

Is It Time To Revisit Sally Beauty Holdings (SBH) After Its 59% One-Year Share Price Jump?

If you are wondering whether Sally Beauty Holdings is still worth your attention at around US$14.54 per share, this article walks through what that price could mean for value focused investors. The stock is roughly flat year to date with a 0.3% return. However, the 59.4% return over the past year, alongside shorter term moves of a 1.7% decline over 7 days and a 4.5% decline over 30 days, suggests sentiment has shifted more than once recently. Recent coverage has focused on Sally Beauty...
NasdaqGS:LSTR
NasdaqGS:LSTRTransportation

How Landstar’s Heavy Haul and Mexico Expansion Amid Softer Freight Demand Will Impact Landstar System (LSTR) Investors

In recent updates, Landstar System expanded its heavy haul and Mexico cross-border services while maintaining dividends, share repurchases, and a lower long-term debt load. This combination of operational expansion and financial conservatism contrasts with softer freight demand and capacity imbalances that have led analysts to trim earnings expectations. Now we’ll explore how analysts’ cautious earnings revisions, despite Landstar’s heavy haul and Mexico expansion, reshape the company’s...
NYSE:KAI
NYSE:KAIMachinery

Kadant (KAI) Valuation Check After Recent Share Price Pullback

Kadant stock moves: how recent returns stack up for long term holders Kadant (KAI) has seen mixed share performance recently, with a 5.5% decline over the past day and about 9.3% over the past month, while the past 3 months show a 3.9% gain. See our latest analysis for Kadant. Zooming out from the recent pullback, Kadant’s 1-day and 30-day share price returns of 5.5% and 9.3% declines contrast with a 6% year to date gain and a 56.2% three year total shareholder return. This suggests momentum...
NasdaqGS:BMBL
NasdaqGS:BMBLInteractive Media and Services

Bumble (BMBL) Is Up 23.2% After AI-Led Bumble 2.0 Reveal And Upbeat 2026 Revenue Guidance

In March 2026, Bumble reported fourth-quarter 2025 results that exceeded revenue and earnings expectations, issued first-quarter 2026 revenue guidance of US$209 million to US$213 million (including US$171 million to US$174 million from the Bumble app), and highlighted stronger profitability despite fewer paying users. The company also unveiled an AI-powered overhaul, including its Bee model, the Dates assistant and the upcoming Bumble 2.0 cloud-native platform, aiming to improve user...
NYSE:PRGO
NYSE:PRGOPharmaceuticals

A Look At Perrigo’s (PRGO) Valuation As UBS Conference Appearance Draws New Attention

Why Perrigo’s UBS conference appearance is drawing fresh attention Perrigo (PRGO) is set to present at the UBS Global Consumer and Retail Conference in New York on March 11, 2026, with President and CEO Patrick Lockwood-Taylor scheduled to speak. The event has put a fresh spotlight on the stock, as investors look for updated commentary on Perrigo’s over the counter health and wellness portfolio, recent financial results, and how management is thinking about capital allocation. See our latest...
NYSE:HUM
NYSE:HUMHealthcare

Is It Time To Reconsider Humana (HUM) After Its Steep Share Price Slide?

If you are looking at Humana and wondering whether the recent share price puts it in bargain territory or not, it helps to start with the facts behind the current valuation story. Humana's share price most recently closed at US$165.43, with returns of a 7.7% decline over 7 days, a 5.7% decline over 30 days, a 37.5% decline year to date, a 33.7% decline over 1 year, a 65.5% decline over 3 years, and a 57.7% decline over 5 years. Recent headlines around Humana have focused on how the share...
NYSE:KNX
NYSE:KNXTransportation

Is Knight-Swift (KNX) Pricing Look Attractive After Recent Share Price Pullback?

If you are wondering whether Knight-Swift Transportation Holdings is attractively priced today, you are not alone. Its recent share performance has put valuation questions front and center. The stock last closed at US$51.93, with a 7 day return of an 8.7% decline, a 30 day return of a 13.8% decline and a 1 year return of 13.3%, which gives mixed signals on how the market is treating the company right now. Recent news around Knight-Swift has focused on its position in the US trucking and...
NYSE:AMTM
NYSE:AMTMProfessional Services

Is It Time To Reassess Amentum Holdings (AMTM) After The Recent Share Price Pullback

If you are wondering whether Amentum Holdings at US$27.90 is offering fair value or an opportunity, you are not alone in asking what the current price really reflects. The stock has seen a mixed return profile, with a 7% decline over the last week and an 8.2% decline over the last month, while still sitting on a 55.9% return over the past year and an 8.5% decline year to date. Recent news coverage around Amentum has focused on its position in the commercial services space and how investors...
NYSE:SHW
NYSE:SHWChemicals

Does Sherwin-Williams’ (SHW) Special-Meeting Standoff Reveal a Deeper Governance Trade-Off for Investors?

On March 11, 2026, shareholder John Chevedden submitted a proposal at The Sherwin-Williams Company to lower the ownership threshold required for investors to call a special shareholder meeting, while the board urged shareholders to vote against it at the April 22, 2026 annual meeting. This clash over special meeting rights highlights ongoing tension between Sherwin-Williams’ management and activist investors regarding how much direct influence shareholders should have over corporate...
NYSE:CLF
NYSE:CLFMetals and Mining

Cleveland Cliffs Faces Fraud Probe As Plant Idling Reshapes Outlook

Portnoy Law Firm has launched a securities fraud investigation into Cleveland-Cliffs (NYSE:CLF) following the company’s recent financial disclosure. Cleveland-Cliffs reported a revenue decline and larger than expected losses, alongside plans to idle six steel plants and exit loss-making business segments. The investigation is being framed as a potential class action on behalf of investors who experienced stock value losses. Cleveland-Cliffs, trading at about $8.46, has seen sharp share...
NYSE:CCS
NYSE:CCSConsumer Durables

Century Communities Expands With Denver Luxury Rental Project The Stevie

Century Communities' multifamily division, Century Living, has acquired a shovel-ready site in Denver's LoHi neighborhood for a luxury apartment project called The Stevie. Groundbreaking is set to begin imminently, with leasing currently projected to start in 2028. The Stevie represents an expansion for NYSE:CCS further into high-end multifamily development in a central Denver location. Century Communities, listed on the NYSE under ticker CCS, is primarily known for building single-family...
NYSE:COUR
NYSE:COURConsumer Services

Coursera (COUR) Valuation Check As User Growth Push Weighs On Revenue Per Customer And Sales Momentum

Why Coursera’s growth push is back in focus Recent commentary on Coursera (COUR) has zeroed in on its choice to prioritize user growth, with average revenue per customer falling 8.1% annually and estimates pointing to slower sales growth ahead. At the same time, Coursera is carrying high marketing expenses to keep attracting learners. This highlights a tension between expanding the platform and improving profitability that many investors are reassessing. See our latest analysis for...
NYSE:NEU
NYSE:NEUChemicals

Is NewMarket (NEU) Pricing Out Of Step After Recent Share Price Declines?

If you are trying to figure out whether NewMarket's current share price fairly reflects its fundamentals, you are in the right place. The stock recently closed at US$584.66, after a 7 day return of an 8.8% decline, a 30 day return of a 16.2% decline, and a year to date return of a 15.0% decline, set against a 1 year return of 13.2%, a 3 year return of 78.2%, and a 5 year return of 66.4%. Recent coverage has focused on how NewMarket's share price performance over multiple time frames may...
NYSE:TYL
NYSE:TYLSoftware

Is Tyler Technologies (TYL) Starting To Look Attractive After Its Recent Share Price Slide

If you are wondering whether Tyler Technologies is starting to look interesting at its current share price, this article will walk through what the numbers are saying about value. The stock closed at US$349.79 most recently, after a 6.6% decline over the last 7 days, a 3.1% gain over 30 days, and returns of 19.7% decline year to date and 37.9% decline over the past year. The 3 year and 5 year returns sit at 7.1% and 16.7% decline respectively. Recent coverage has continued to focus on Tyler...
NasdaqGS:BLKB
NasdaqGS:BLKBSoftware

Is It Time To Reassess Blackbaud (BLKB) After The Recent Share Price Slide

If you are looking at Blackbaud and wondering whether the current share price reflects its true worth, you are not alone. This article is built to help you weigh what you are paying against what you are getting. The stock most recently closed at US$44.03, with returns of an 8.6% decline over the last 7 days, a 12.6% decline over the last 30 days, a 26.0% decline year to date and a 30.6% decline over the past year, alongside a 22.9% decline over three years and a 37.9% decline over five...
NasdaqGS:QRVO
NasdaqGS:QRVOSemiconductor

Will Strong High Performance Analog Results and Segment Growth Change Qorvo's (QRVO) Narrative

Earlier this week, Qorvo reported an exceptional quarter with revenue up 8.4% year on year, beating analyst expectations for earnings per share and adjusted operating income, as all operating segments grew, led by automotive components, consumer and enterprise Wi‑Fi, base stations, and power management. Management also flagged an expected seasonal dip tied to its largest customer and the ongoing resizing of its Android business, while emphasizing continued strength in its High Performance...
NYSE:CE
NYSE:CEChemicals

Is Celanese (CE) Pricing Reflect Its Potential After Recent Share Price Swings

If you are wondering whether Celanese's current share price reflects its true worth, this article will walk through the numbers in plain English so you can judge the value story for yourself. The stock recently closed at US$57.74, with returns of 17.1% over the last 7 days, a 4.7% decline over 30 days, 37.0% year to date, 1.5% over 1 year, a 41.6% decline over 3 years, and a 57.5% decline over 5 years. This gives a mixed picture for anyone thinking about risk and opportunity. Recent coverage...
NYSE:WMK
NYSE:WMKConsumer Retailing

Weis Markets (WMK) Margin Compression To 1.9% TTM Tests Defensive Grocer Narratives

Weis Markets (WMK) has wrapped up FY 2025 with fourth quarter revenue of US$1.3b, basic EPS of US$1.11 and net income of US$28.5m, setting the tone for how investors will read the latest set of numbers. Over recent quarters, revenue has ranged from US$1.20b in Q1 2025 to US$1.30b in Q4 2025, while basic EPS has moved between US$0.74 and US$1.11 over the same period, giving you a clear view of how sales and earnings have tracked through the year. With trailing twelve month net profit margin...
NasdaqGM:FIVN
NasdaqGM:FIVNSoftware

Legal Review Of Five9 Leadership Puts Governance And AI Ambitions In Focus

A law firm has launched an investigation into Five9's officers and directors over potential breaches of fiduciary duty to shareholders of NasdaqGM:FIVN. The probe focuses on whether management may have failed to act in shareholders' best interests, which could raise corporate governance concerns. This legal review has not been widely reported yet, making it a fresh development for existing and prospective investors. Five9, listed on NasdaqGM:FIVN, provides cloud contact center software used...
NYSE:HWM
NYSE:HWMAerospace & Defense

Is It Too Late To Consider Howmet Aerospace (HWM) After 7x Multi Year Share Gains?

If you are wondering whether Howmet Aerospace is still good value after its recent run, you are not alone. This article will focus squarely on what you are paying for each dollar of the business. The stock last closed at US$236.75, with returns of 11.8% year to date and 87.6% over the past year, while the last 7 days showed a 5.3% decline and the past 30 days showed a 2.6% gain. Recent headlines around Howmet Aerospace have focused on its role as an aerospace and industrial supplier,...